Stock IOT INNOVOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Innovotech Inc.

Equities

IOT

CA45772U1049

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 01:07:14 08/05/2024 am IST 		5-day change 1st Jan Change
0.12 CAD +20.00% Intraday chart for Innovotech Inc. 0.00% +60.00%
25/04 Innovotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Innovotech Inc. Announces CFO Changes CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2.174 4.168 7.465 7.393 5.253 2.918
Enterprise Value (EV) 1 2.246 4.171 6.935 7.02 4.739 2.69
P/E ratio -16.8 x -85.5 x 69.2 x 20.1 x -38.5 x -18.5 x
Yield - - - - - -
Capitalization / Revenue 2.63 x 4.23 x 6.26 x 4.99 x 4.67 x 2.47 x
EV / Revenue 2.72 x 4.23 x 5.81 x 4.74 x 4.21 x 2.27 x
EV / EBITDA -20.1 x -142 x 59.1 x 20.7 x -180 x -7.98 x
EV / FCF -9.2 x 48.4 x 64 x -71.3 x 25.4 x -14.2 x
FCF Yield -10.9% 2.07% 1.56% -1.4% 3.94% -7.03%
Price to Book 23.3 x 42.5 x 11.6 x 6.28 x 4.97 x 3.14 x
Nbr of stocks (in thousands) 36,240 36,240 38,285 38,910 38,910 38,910
Reference price 2 0.0600 0.1150 0.1950 0.1900 0.1350 0.0750
Announcement Date 26/04/19 29/04/20 20/04/21 26/04/22 25/04/23 24/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.8269 0.9862 1.193 1.482 1.126 1.183
EBITDA 1 -0.1116 -0.0295 0.1173 0.3388 -0.0263 -0.3369
EBIT 1 -0.127 -0.0428 0.0993 0.268 -0.1404 -0.3797
Operating Margin -15.36% -4.34% 8.32% 18.08% -12.48% -32.1%
Earnings before Tax (EBT) 1 -0.1276 -0.0488 0.1063 0.3671 -0.1365 -0.1576
Net income 1 -0.1276 -0.0488 0.1063 0.3671 -0.1365 -0.1576
Net margin -15.43% -4.94% 8.91% 24.78% -12.13% -13.32%
EPS 2 -0.003582 -0.001345 0.002816 0.009457 -0.003508 -0.004049
Free Cash Flow 1 -0.2441 0.0861 0.1083 -0.0984 0.1869 -0.189
FCF margin -29.52% 8.74% 9.08% -6.64% 16.6% -15.98%
FCF Conversion (EBITDA) - - 92.4% - - -
FCF Conversion (Net income) - - 101.9% - - -
Dividend per Share - - - - - -
Announcement Date 26/04/19 29/04/20 20/04/21 26/04/22 25/04/23 24/04/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.07 0 - - - -
Net Cash position 1 - - 0.53 0.37 0.51 0.23
Leverage (Debt/EBITDA) -0.6378 x -0.1129 x - - - -
Free Cash Flow 1 -0.24 0.09 0.11 -0.1 0.19 -0.19
ROE (net income / shareholders' equity) -92.8% -50.9% 28.6% 40.3% -12.2% -15.3%
ROA (Net income/ Total Assets) -19.9% -9.77% 11.3% 14.9% -6.61% -19.5%
Assets 1 0.6429 0.4992 0.9397 2.472 2.065 0.81
Book Value Per Share 2 0 0 0.0200 0.0300 0.0300 0.0200
Cash Flow per Share 2 0 0 0.0100 0.0100 0.0100 0
Capex 1 0.01 0 0.04 0.06 0.07 0.04
Capex / Sales 1.13% 0.25% 3.16% 4.06% 6.35% 3.63%
Announcement Date 26/04/19 29/04/20 20/04/21 26/04/22 25/04/23 24/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
INNOVOTECH INC. Stock Innovotech Inc.
+60.00% 34.39L
MODERNA, INC. Stock Moderna, Inc.
+41.79% 5.4TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.56% 4.19TCr
LONZA GROUP AG Stock Lonza Group AG
+49.62% 4.2TCr
CELLTRION, INC. Stock Celltrion, Inc.
-7.20% 2.84TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.59% 2.64TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.51% 1.9TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+6.92% 1.3TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.91% 1.22TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.60% 1.23TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. IOT Stock
  4. Financials Innovotech Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW